Your browser is no longer supported. Please, upgrade your browser.
Settings
LGVN [NASD]
Longeveron Inc.
Index- P/E- EPS (ttm)-0.77 Insider Own- Shs Outstand19.11M Perf Week346.43%
Market Cap401.78M Forward P/E- EPS next Y- Insider Trans- Shs Float2.91M Perf Month778.80%
Income-14.30M PEG- EPS next Q- Inst Own8.90% Short Float7.35% Perf Quarter768.84%
Sales2.30M P/S174.69 EPS this Y-25.70% Inst Trans-5.05% Short Ratio0.02 Perf Half Y364.70%
Book/sh1.17 P/B26.21 EPS next Y- ROA-58.10% Target Price- Perf Year-
Cash/sh1.44 P/C21.26 EPS next 5Y- ROE-76.00% 52W Range2.84 - 45.00 Perf YTD313.90%
Dividend- P/FCF- EPS past 5Y- ROI-151.10% 52W High-31.84% Beta-
Dividend %- Quick Ratio10.20 Sales past 5Y- Gross Margin46.10% 52W Low979.89% ATR5.63
Employees12 Current Ratio10.20 Sales Q/Q-95.50% Oper. Margin- RSI (14)66.39 Volatility116.27% 39.87%
OptionableNo Debt/Eq0.00 EPS Q/Q-100.90% Profit Margin- Rel Volume2.11 Prev Close42.30
ShortableNo LT Debt/Eq0.00 EarningsNov 12 BMO Payout- Avg Volume9.87M Price30.67
Recom- SMA20288.73% SMA50477.01% SMA200414.13% Volume20,781,202 Change-27.49%
Nov-24-21 06:20PM  
12:25PM  
Nov-23-21 04:22PM  
Nov-22-21 04:59PM  
03:42PM  
Nov-19-21 06:19AM  
Nov-18-21 02:31PM  
12:33PM  
10:57AM  
10:37AM  
10:21AM  
08:00AM  
07:04AM  
Nov-14-21 11:55PM  
Nov-12-21 02:22PM  
11:00AM  
10:49AM  
08:00AM  
07:55AM  
Nov-11-21 06:50PM  
Nov-10-21 02:54PM  
01:15PM  
10:45AM  
10:00AM  
Nov-09-21 03:06PM  
02:48PM  
01:55PM  
01:15PM  
09:20AM  
Nov-08-21 01:03PM  
12:00PM  
11:00AM  
08:30AM  
07:40AM  
Nov-07-21 10:40PM  
08:39PM  
01:15PM  
Nov-05-21 06:05PM  
03:45PM  
02:30PM  
01:42PM  
12:25PM  
11:00AM  
08:30AM  
Nov-04-21 08:15AM  
Nov-03-21 10:55PM  
05:15PM  
01:34PM  
11:00AM  
09:58AM  
07:45AM  
01:10AM  
Nov-02-21 09:00PM  
10:29AM  
08:00AM  
Nov-01-21 07:45PM  
04:00PM  
02:16PM  
01:10PM  
Oct-31-21 09:45AM  
Oct-29-21 04:30PM  
03:58PM  
Oct-28-21 03:00PM  
11:00AM  
Oct-27-21 10:55PM  
10:41PM  
09:00PM  
05:21PM  
03:45PM  
Oct-26-21 03:45PM  
03:35PM  
10:00AM  
Oct-25-21 11:32PM  
02:40PM  
11:00AM  
Oct-23-21 09:15AM  
Oct-22-21 05:06PM  
11:00AM  
Oct-21-21 03:30PM  
11:00AM  
Oct-20-21 07:58PM  
08:30AM  
Oct-19-21 09:00PM  
05:45PM  
01:15PM  
11:00AM  
Oct-18-21 07:48PM  
Oct-17-21 10:00AM  
Oct-16-21 08:59AM  
Oct-15-21 08:53PM  
05:12PM  
Oct-14-21 04:19PM  
02:50PM  
08:00AM  
Oct-13-21 10:00PM  
07:53PM  
05:50PM  
04:10PM  
09:52AM  
Oct-12-21 12:15PM  
Longeveron Inc., a clinical stage biotechnology company, engages in developing cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. It is conducting Phase 1 and 2 clinical trials in various indications comprising aging frailty, alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left heart syndrome. The company was incorporated in 2014 and is headquartered in Miami, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Green GeoffCEOOct 13Buy3.811,0003,810139,723Oct 14 09:00 AM
Soffer RockDirectorOct 13Buy3.7612,00045,12051,757Oct 13 06:00 PM
Hare JoshuaChief Scientific OfficerOct 12Buy3.692,5009,2257,933,263Oct 14 09:00 AM
Soffer RockDirectorOct 12Buy3.574,00014,28039,757Oct 13 06:00 PM
Soffer RockDirectorOct 11Buy3.453,90013,45535,757Oct 13 06:00 PM
Hare JoshuaChief Scientific OfficerOct 08Buy3.393,01510,2217,930,763Oct 12 09:30 AM
Clavijo JamesCFO and TreasurerOct 07Buy3.345,00016,70079,598Oct 12 09:30 AM
Hare JoshuaChief Scientific OfficerOct 07Buy3.381,9856,7097,927,748Oct 12 09:30 AM
Lehr Paul TGeneral Counsel, SecretaryOct 07Buy3.341,7505,845116,366Oct 12 09:30 AM
Soffer Donald MDirectorFeb 12Buy10.00100,0001,000,000153,514Feb 26 06:00 PM
Soffer RockDirectorFeb 12Buy8.0510080526,857Feb 26 06:00 PM